首页|期刊导航|Oncology Research|SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma
Oncology Research2026,Vol.34Issue(6):P.539-562,24.DOI:10.32604/or.2026.078376
SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma
摘要
关键词
Sideroflexin 3(SFXN3)/head and neck squamous cell carcinoma(HNSCC)/bioinformatics/The Cancer Genome Atlas(TCGA)/biomarker/prognosis/tumor microenvironment分类
医药卫生引用本文复制引用
Eun-Jeong Jeong,Yeon Soo Kim,Yujin Lee,Jae-Sung Ryu,Yung Hyun Choi,Eunjeong Kim..SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma[J].Oncology Research,2026,34(6):P.539-562,24.基金项目
supported by the National Research Foundation of Korea(NRF)grant,funded by the Korean government(MSIT)(Grant Numbers:RS-2023-00217899 and RS-2024-00453724) (NRF)
This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF)funded by the Ministry of Education RS-2025-25437414. (NRF)